K. Wyatt Engwall serves as Executive at THERAGENICS CORP, where they oversee executive responsibilities. Since joining the company, K. Wyatt Engwall has executed 14 insider transactions totaling $200.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 29, 2013 involved selling 209,550 shares valued at $461.0K.
K. Wyatt Engwall currently holds 209,550 shares of THERAGENICS CORP (TGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, K. Wyatt Engwall has been a net buyer of TGX stock. They have purchased $200.0K and sold $0 worth of shares.
K. Wyatt Engwall's most recent insider trade was on Oct 29, 2013, when they sold 209,550 shares at $2.20 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 16, 2012 | TGX | $0 | Award | 15,000 | $N/A | Discretionary |
| May 18, 2012 | TGX | $0 | Award | 15,000 | $N/A | Discretionary |
| May 20, 2011 | TGX | $0 | Award | 15,000 | $N/A | Discretionary |
| Jun 3, 2010 | TGX | $1.4K | Purchase | 1,250 | $1.16 | Discretionary |
| Jun 1, 2010 | TGX | $31.2K | Purchase | 26,200 | $1.19 | Discretionary |
| May 13, 2010 | TGX | $0 | Award | 5,000 | $N/A | Discretionary |
| Feb 19, 2010 | TGX | $67.5K | Purchase | 50,000 | $1.35 | Discretionary |
| May 14, 2009 | TGX | $0 | Award | 5,000 | $N/A | Discretionary |
| Nov 6, 2008 | TGX | $29.8K | Purchase | 21,100 | $1.41 | Discretionary |
| Aug 28, 2008 | TGX | $33.2K | Purchase | 10,000 | $3.32 | Discretionary |
| Aug 26, 2008 | TGX | $37.0K | Purchase | 11,000 | $3.36 | Discretionary |
| May 15, 2008 | TGX | $0 | Award | 5,000 | $N/A | Discretionary |